Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Zi-Jun XuYe JinXin-Long ZhangPei-Hui XiaXiang-Mei WenJi-Chun MaJiang LinJun Qian

Published in: Cancer medicine (2022)

Our study demonstrated CD300s as potential prognostic biomarker and an ideal immunotherapy target in AML, which warrants future functional and clinical studies.

Keyphrases

papillary thyroid
acute myeloid leukemia
genome wide
human health
transcription factor
current status
young adults
dna methylation
lymph node metastasis